A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations